Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 22 - Number 16

Review Article (Mini-Review)

Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy

, 22(16): 1810 - 1824

Siddhi Dilip Chalke and Pravin Popatrao Kale*

DOI: 10.2174/1389450122666210319113136

Review Article

Review Article

ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect

, 22(16): 1832 - 1843

Shuainan Li, Wenya Ma, Fan Yang, Yan Xu, Binbin Xu and Benzhi Cai*

DOI: 10.2174/1389450122666210319110320

Review Article

Recent Progress on Apoptotic Activity of Triazoles

, 22(16): 1844 - 1900

P. Çıkla-Süzgün and Ş.G. Küçükgüzel*

DOI: 10.2174/1389450122666210208181128

Review Article

3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges

, 22(16): 1901 - 1914

Prasanna Kumar Desu, Balaji Maddiboyina, Kondi Vanitha, Shiva Naga Koteswara Rao Gudhanti, Rapuri Anusha and Vikas Jhawat*

DOI: 10.2174/1389450122666210120142416


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog